Short Interest in FOXO Technologies Inc. (NYSEAMERICAN:FOXO) Declines By 49.2%

FOXO Technologies Inc. (NYSEAMERICAN:FOXO) was the target of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 960,200 shares, a decline of 49.2% from the February 28th total of 1,890,000 shares. Approximately 3.3% of the shares of the company are short sold. Based on an average daily trading volume, of 7,110,000 shares, the days-to-cover ratio is currently 0.1 days.

FOXO Technologies Stock Performance

NYSEAMERICAN FOXO traded down $0.01 during mid-day trading on Friday, reaching $0.13. 1,365,433 shares of the stock were exchanged, compared to its average volume of 14,627,025. FOXO Technologies has a 1 year low of $0.13 and a 1 year high of $1.30. The business has a 50 day simple moving average of $0.27.

Institutional Investors Weigh In On FOXO Technologies

A hedge fund recently bought a new stake in FOXO Technologies stock. Jane Street Group LLC purchased a new position in FOXO Technologies Inc. (NYSEAMERICAN:FOXO) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 117,047 shares of the company’s stock, valued at approximately $34,000. Jane Street Group LLC owned approximately 0.67% of FOXO Technologies as of its most recent filing with the Securities and Exchange Commission. 44.89% of the stock is currently owned by hedge funds and other institutional investors.

FOXO Technologies Company Profile

FOXO Technologies Inc engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging.